Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elvio G. Silva is active.

Publication


Featured researches published by Elvio G. Silva.


Cancer | 1982

Neuroblastomas and neuroendocrine carcinomas of the nasal cavity. A proposed new classification

Elvio G. Silva; James J. Butler; Bruce Mackay; Helmuth Goepfert

The histologic characteristics of 29 nasal tumors previously diagnosed as neuroblastomas, unclassified carcinomas, or unclassified malignant neoplasms were reviewed. Electron microscopy was performed in 17. Nine tumors were neuroblastomas; six of these were classical neuroblastomas while the other three exhibited olfactory differentiation in addition to the classical neuroblastoma component. Areas of ganglioneuroblastoma were found in the metastasis of one of the three olfactory neuroblastomas. Twenty tumors were classified as neuroendocrine carcinoma because all showed a neuroendocrine pattern with remarkably uniform cells growing from benign glandular epithelium; membrane bound granules were present in the cytoplasm of cells of the ten cases in this group examined by electron microscopy. The mean age of the patients with neuroblastomas was 20 years; survival in this group was 75% at five and seven years, respectively, and 67% at ten years. Recurrences, metastasis, and death occurred within 3 years of diagnosis. There was a low percentage (25%) of multiple recurrences. The metastases were located in cervical lymph nodes, brain and spine. The mean age of the patients with neuroendocrine carcinoma was 50 years. Survival was 100% at five years, 88% at seven years, and 77% at ten years. Recurrences and metastasis in 70% of the cases occurred later than the third year. Multiple recurrences were present in 54% of the cases. The metastases affected lymph nodes, brain and spine in all cases except in one in which lungs and femur were involved. In the latter case adenocarcinoma was also present in addition to the neuroendocrine carcinoma. Three patients died, all more than five years from the time of diagnosis. No correlation was found between staging and prognosis in either group, except for Stage I disease.


Obstetrical & Gynecological Survey | 1999

A RANDOMIZED CLINICAL TRIAL OF CRYOTHERAPY, LASER VAPORIZATION, AND LOOP ELECTROSURGICAL EXCISION FOR TREATMENT OF SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX

Michele Follen Mitchell; Guillermo Tortolero-Luna; Elise Cook; Lori Whittaker; Helen Rhodes-Morris; Elvio G. Silva

: Women at least 18 years old with biopsy-provenSIL, negative pregnancy tests, negative findings on endocer-vical curettage, satisfactory colposcopy examinations, andcongruent Papanicolaou smear and biopsy results wereassigned randomly to treatment after stratification by SILgrade, endocervical gland involvement, and lesion size; theywere evaluated 1, 4, 8, 12, 16, 20, and 24 months aftertreatment. Data were analyzed using


International Journal of Gynecological Pathology | 1994

Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen.

Elvio G. Silva; Carmen Tornos; Michele Follen-Mitchell

We reviewed the clinical history and pathology material of 72 patients seen at the M. D. Anderson Cancer Center who developed malignant neoplasms of the uterine corpus after being treated for breast carcinoma with either tamoxifen or other therapeutic regimens. The purpose of this study was to investigate the type of malignant tumors seen in the uterus, their association with endometrial polyps or hyperplasia, and their possible relationship to tamoxifen treatment. This study shows that in patients treated for breast carcinoma, the uterine malignancies are characterized by several features: (a) a previously unreported high incidence of clear cell carcinoma (14 cases) and leiomyosarcoma (12 cases); (b) seven of 12 leiomyosarcomas with unusual features, such as epithelioid (5), tubular (1), and myxoid features (2); (c) a higher incidence of serous carcinoma (45% in patients treated for > or = 12 months); (d) endometrial polyps associated with carcinoma more often than endometrial hyperplasia.


Gynecologic Oncology | 1989

Clear cell carcinoma of the ovary: A study of 59 cases

Mark A. Crozier; Larry J. Copeland; Elvio G. Silva; David M. Gershenson; C.Allen Stringer

Clear cell carcinoma of the ovary accounts for 2 to 3% of all epithelial ovarian neoplasms. Patient profiles, pathological characteristics, and results of treatment are reviewed for 59 patients. The median age was 51. Disease extent at diagnosis was as follows: stage I, 18 patients (31%); stage II, 20 patients (34%); stage III, 15 patients (25%); stage IV, 3 patients (5%); and unknown stage, 3 patients (5%). Endometriosis was identified in 13 patients (22%). Hysterectomy and bilateral salpingo-oophorectomy were performed in 47 patients (80%), unilateral salpingo-oophorectomy in 8 patients (14%), and bilateral salpingo-oophorectomy in 4 patients (7%). Radiotherapy was given to 15 patients (25%), and chemotherapy was given to 42 patients (71%). The overall 2- and 5-year survival rates were 49 and 43%. The median survival was 26 months. Patients with tumors with fewer than 10 mitoses per 10 high-power fields and less than 50% solid areas had significantly longer disease-free intervals. Clear cell tumors are usually diagnosed at an earlier disease stage than the other epithelial ovarian cancers; stage for stage, however, the prognoses are similar.


International Journal of Gynecological Pathology | 1996

Transitional cell neoplasms of the ovary and urinary bladder : A comparative immunohistochemical analysis

Robert A. Soslow; Robert V. Rouse; Michael R. Hendrickson; Elvio G. Silva; Teri A. Longacre

Walthard cell nests, the Brenner tumor (benign, proliferating, low malignant potential, and malignant), and primary ovarian transitional cell carcinoma are considered to be primary female genital tract proliferations of transitional-type (urothelial) epithelium on conventional light microscopic grounds. In order to further investigate the similarities (or dissimilarities) of proliferations of female genital tract transitional epithelium and urothelium, we compared transitional cell proliferations (TCPs) of the female genital tract (n = 25) and urinary bladder (n = 15) using antibodies to carcinoembryonic antigen (CEA; clone 0062), carbohydrate determinant 19-9 (CA19-9; clone 1116-NS-19-9), cytokeratin 7 (CK-7; clone OV-TL 12/30), and cytokeratin 20 (CK-20; clone Ks 20.8), four monoclonal antibodies that have been shown to stain transitional cell urothelial proliferations. Both groups of tumors exhibited significant staining for CEA, CA19-9, and CK-7, and the difference in numbers of cases staining was not significant. CA19-9 was present in 15 of 25 female genital tract TCPs as compared with 12 of 15 bladder TCPs; CEA was present in 17 of 25 female genital tract TCPs and nine of 15 comparable bladder TCPs. CK-7 was present in all cases studied with the exception of one Walthard cell nest and a malignant Brenner tumor that was not immunoreactive with the other antibodies tested. In contrast, 13 of 15 bladder TCPs were CK-20 positive, whereas only one of 25 female genital tract TCPs was positive (< 5% of cells). Walthard cell nests and benign Brenner tumors were more likely to be CA19-9 positive than were Brenner tumors of low malignant potential, malignant Brenner tumors, and primary transitional cell carcinoma of the ovary. We conclude that despite their apparent morphologic and immunologic similarity to TCPs of the urinary bladder (particularly at the histologically low-grade end of the transitional cells spectrum), Walthard cell nests and ovarian Brenner tumors constitute an immunophenotypically distinct form of TCP.


Cancer | 1988

Spermatocytic seminoma with associated sarcoma of the testis

Craig Floyd; Alberto G. Ayala; Elvio G. Silva; Christopher J. Logothetis

Spermatocytic seminoma is a clinical pathologic distinct entity that has a good prognosis and rarely is associated with other neoplastic elements. Two cases of testicular Spermatocytic seminoma with a sarcomatous element are reported. Both patients were older than 40 years and presented with 1‐year and 2‐year histories of progressive testicular enlargement and recent onset of testicular pain. Histologically, the spermatocytic seminoma in both cases consisted of three distinct cell types as has been previously described. Ultrastructurally, one case showed crystalloid structures similar to the Lubarschs crystalloids described in spermatogonia of human testis. The sarcomatous component in one case was a rhabdomyosarcoma confirmed by light and by electron microscopic study whereas the second case was a primitive mesenchymal spindle cell sarcoma. Only the sarcomatous element metastasized; metastatic sites included lung and paraaortic lymph nodes in the first patient and lung and liver in the second. Despite aggressive treatment with combined surgery and multiagent chemotherapy, the first patient died within 1 year of diagnosis and the second at 14 months.


Cancer | 1984

Endocrine carcinoma intermediate cell type of the uterine cervix

Elvio G. Silva; Marylee M. Kott; Nelson G. Ordóñez

Nine cases of endocrine carcinoma, intermediate‐cell type of the uterine cervix, were found in a study of 404 cases listed in the files of the University of Texas M. D. Anderson Hospital and Tumor Institute at Houston as adenocarcinoma of the cervix. Based on light microscopic patterns, these cases were divided into pure endocrine carcinoma (six cases), and endocrine carcinoma mixed with adenocarcinoma (three cases). All tumors were 3 cm or larger in at least one dimension. On light microscopic examination, the predominant pattern was trabecular; however, insular, glandular, and spindle patterns were also identified. Argyrophilic granules were demonstrated in all cases by Grimelius stain, and Fontana‐Masson (argentaffin) stain was negative. Electron microscopic examination of three cases showed membrane‐bound, dense‐core granules of the neurosecretory type. Although no endocrine symptoms were found, immunoperoxidase studies demonstrated 5‐hydroxytryptamine in seven cases, substance P in three, vasointestinal polypeptide in two, pancreatic polypeptide in one, and somatostatin in one. Clinical behavior of these tumors was extremely agressive. Although five cases were Stage IB at presentation, two Stage IIB, one Stage IIIB, and one Stage IV, 87.5% of these patients died of their neoplasms within 3 years. This study emphasizes the importance of correctly diagnosing endocrine carcinoma, intermediate‐cell type in the uterine cervix, because of the poor prognosis of this tumor when compared with adenocarcinoma of the cervix.


International Journal of Gynecological Pathology | 1993

Multiple nodules of intermediate trophoblast following hydatidiform moles

Elvio G. Silva; Carmen Tornos; Janice M. Lage; Nelson G. Ordóñez; Mitchell Morris; John J. Kavanagh

After removal of a complete hydatidiform mole, seven patients developed an unusual complication characterized by a proliferation of intermediate trophoblast-forming nodules in the endometrium or myometrium. The patients were examined because of vaginal bleeding or mildly elevated human chorionic gonadotrophin (HCG) titers. Three patients were cured by hysterectomy, one by endometrial curettage, one by endometrial curettage plus chemotherapy, and one (who also had choriocarcinoma) by multiple doses of chemotherapy after hysterectomy; the seventh patient was lost to follow-up. These nodules probably represent a mild form of postmolar trophoblastic disease.


International Journal of Radiation Oncology Biology Physics | 1988

Primary squamous cell carcinoma of the vagina treated by radiotherapy: A failures analysis—The M. D. Anderson hospital experience 1955–1982

Frank Dancuart; Luis Delclos; J. Taylor Wharton; Elvio G. Silva

The retrospective study concerns 167 patients with primary squamous cell carcinoma of the vagina treated at The University of Texas M. D. Anderson Hospital and Tumor Institute between January 1955 and December 1982. Of these 167 patients, 162 were evaluable and 5 were lost to follow-up. For small tumors, localized treatment by brachytherapy alone, transvaginal irradiation with 125 to 250 kV alone or in combination with brachytherapy, was mainly used, with emphasis on use of colpostats and transvaginal irradiation for tumors of the upper half of the vagina and interstitial (with radium needles or, later, afterloaded stainless-steel guides with iridium wires) for the lower half. For medium-size tumors, local treatment was combined with external irradiation, mainly using conservative-size fields. For the majority of larger tumors or when the anatomy was distorted, external irradiation alone was used, also with portals of conservative size. Failures were analyzed in relation to FIGO (International Federation of Obstetrics and Gynecology) staging, tumor location, and modality of treatment. As expected, central failures were higher in Stage III disease (9 of 38 patients, 24%) but also uncomfortably high for Stage I patients (13 of 71 patients, 18%) treated locally or with external and local irradiation. The incidence of central treatment failures in tumors of the lower vagina (13/51 patients, 25%) was somewhat higher than for tumors located in the upper vagina (13/85 patients, 15%), but the percentage of large tumors in the lower vagina was 53% compared with 31% in the upper vagina. Severe complications were related to high doses of irradiation alone or in combination with aggressive surgery, and to pelvic inflammatory disease.


International Journal of Gynecological Pathology | 1991

Ovarian and juxtaovarian adenomatoid tumors : a report of six cases

Robert H. Young; Elvio G. Silva; Robert E. Scully

Five ovarian adenomatoid tumors and one Juxtaovarian tumor of this type in women 23 to 79 (average 54) years of age are described. Four were <7 mm in diameter: the other two were 1.4 cm and 5 cm. The five ovarian tumors were located predominantly in the hilus, with focal extension into the medulla. Microscopic examination showed the lesions to he characterized by round, oval, or elongated tubules, some of which were cystically dilated, and vacuoles occasionally containing basophilic secretion. Hyaline bodies were present in one case. Follow-up in these cases and the 10 previously reported similar cases that include follow-up information has been benign. The microscopic features of the ovarian adenomatoid tumor are typically diagnostic, but, as illustrated by one of our cases and another in the literature, some features that simulate those of yolk sac tumor may cause diagnostic difficulty when the tumor occurs in a young patient.

Collaboration


Dive into the Elvio G. Silva's collaboration.

Top Co-Authors

Avatar

Andres A. Roma

University of California

View shared research outputs
Top Co-Authors

Avatar

David M. Gershenson

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

J. Taylor Wharton

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Kay J. Park

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

John J. Kavanagh

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Nelson G. Ordóñez

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Isabel Alvarado-Cabrero

Mexican Social Security Institute

View shared research outputs
Top Co-Authors

Avatar

Carmen Tornos

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Helmuth Goepfert

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Joanne Rutgers

Cedars-Sinai Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge